Gold Silver Reports (GSR) – Unichem Labs Surges On U.S. FDA’s Inspection With No Observations — Unichem Labs Surges On U.S. FDA’s Inspection With No Observations – Shares of the Mumbai-based drug maker rose as much as 8.7 percent, the most in over three months, to Rs 283.10 after the U.S. FDA completed inspection of its Ghaziabad unit with no observation, the company said in an exchange notification.
